Netherlands vs Paraguay: HIV/AIDS deaths averted by antiretroviral therapy
Netherlands
754.52 deaths
in 2023
Paraguay
748.25 deaths
in 2024
Netherlands rank
81st
Paraguay rank
82nd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Netherlands
- Paraguay
How they compare
Netherlands currently reports 754.52 deaths against 748.25 deaths in Paraguay, a difference of 6.27 deaths.
The two have swapped places 1 time across 34 shared years of data; in 1990 it was Paraguay ahead.
Netherlands ranks 81st and Paraguay ranks 82nd of 157 countries.
Netherlands has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Netherlands | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 194.11 deaths | 0 deaths | 194.11 deaths | Netherlands |
| 2000s | 651.7 deaths | 104.86 deaths | 546.84 deaths | Netherlands |
| 2010s | 818.94 deaths | 475.81 deaths | 343.13 deaths | Netherlands |
| 2020s | 771.54 deaths | 678.44 deaths | 93.09 deaths | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Netherlands or Paraguay?
- Netherlands, at 754.52 deaths against 748.25 deaths in Paraguay as of 2023.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Netherlands and Paraguay?
- 6.27 deaths, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Paraguay?
- 34 years are reported by both, from 1990 to 2023.
- How do Netherlands and Paraguay rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Netherlands ranks 81st and Paraguay ranks 82nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.